149 related articles for article (PubMed ID: 7565992)
1. More on interferon-induced cutaneous necrosis.
Shinohara K
N Engl J Med; 1995 Nov; 333(18):1222; author reply 1223-4. PubMed ID: 7565992
[No Abstract] [Full Text] [Related]
2. Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b.
Sheremata WA; Taylor JR; Elgart GW
N Engl J Med; 1995 Jun; 332(23):1584. PubMed ID: 7739724
[No Abstract] [Full Text] [Related]
3. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
[No Abstract] [Full Text] [Related]
4. Dermal fibrosis and cutaneous necrosis after recombinant interferon-beta1a injection in a multiple sclerosis patient.
Ozden MG; Erel A; Erdem O; Oztas MO
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):112-3. PubMed ID: 15649205
[TBL] [Abstract][Full Text] [Related]
5. More on interferon-induced cutaneous necrosis.
Trautinger F; Knobler RM
N Engl J Med; 1995 Nov; 333(18):1222-3; author reply 1223-4. PubMed ID: 7565993
[No Abstract] [Full Text] [Related]
6. Rapidly progressive renal graft failure associated with interferon-alpha treatment in a patient with chronic myelogenous leukemia.
Bren A; Kandus A; Ferluga D
Clin Nephrol; 1998 Oct; 50(4):266-7. PubMed ID: 9799075
[No Abstract] [Full Text] [Related]
7. Interferon-associated retinopathy.
Savant V; Gillow T
Eye (Lond); 2003 May; 17(4):534-6. PubMed ID: 12802361
[No Abstract] [Full Text] [Related]
8. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
Olesen LH; Pedersen BB
Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
[TBL] [Abstract][Full Text] [Related]
9. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.
Almeida L; Neves M; Cardoso E; Melo A
J Clin Pharm Ther; 2009 Feb; 34(1):125-7. PubMed ID: 19125911
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary results of interferon alpha treatment for patients with chronic myelogenous leukemia].
Popławska-Szczygłowska L; Starzyńska J; Chmarzyńska-Mróz E
Pol Tyg Lek; 1996 May; 51(19-22):283-4. PubMed ID: 9289711
[No Abstract] [Full Text] [Related]
11. [Embolia cutis medicamentosa after subcutaneous injection of pegylated interferon-alpha].
Sonntag M; Hodzic-Avdagic N; Bruch-Gerharz D; Neumann NJ
Hautarzt; 2005 Oct; 56(10):968-9. PubMed ID: 16142495
[No Abstract] [Full Text] [Related]
12. Interferon-beta injection site reaction: review of the histology and report of a lupus-like pattern.
Conroy M; Sewell L; Miller OF; Ferringer T
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S48-9. PubMed ID: 18625386
[No Abstract] [Full Text] [Related]
13. [Treatment of chronic myeloid leukemia with interferon-alpha].
Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
[TBL] [Abstract][Full Text] [Related]
14. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous reactions associated with alpha interferon therapy.
Stafford-Fox V; Guindon KM
Clin J Oncol Nurs; 2000; 4(4):164-8. PubMed ID: 11261097
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
Bremer CT; Lastrapes A; Alper AB; Mudad R
Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
[TBL] [Abstract][Full Text] [Related]
17. [Interferon-alpha therapy in chronic myelogenous leukemia].
Ohnishi K
Rinsho Ketsueki; 2000 Apr; 41(4):275-9. PubMed ID: 10846454
[No Abstract] [Full Text] [Related]
18. Behçet's disease induced by interferon therapy for chronic myelogenous leukemia.
Segawa F; Shimizu Y; Saito E; Kinoshita M
J Rheumatol; 1995 Jun; 22(6):1183-4. PubMed ID: 7674251
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune phenomena associated with cutaneous aseptic necrosis during interferon-alpha treatment for chronic myelogenous leukaemia.
Lévesque H; Cailleux N; Moore N; Tilly H; Monconduit M; Courtois H
Br J Rheumatol; 1995 Jun; 34(6):582-3. PubMed ID: 7633806
[No Abstract] [Full Text] [Related]
20. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
Nakamura Y; Kawachi Y; Furuta J; Otsuka F
Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
